Acinetobacter meningitis: Four nosocomial cases

Journal of the Formosan Medical Association

Volumn 98, Issue 3, 1999, Pages 214-217

  Chang, Wen Neng ^a,b   Chuang, Yao Chung ^a   Lu, Cheng Hsien ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Acinetobacter meningitis; Imipenem cilastatin; Multiantibiotic resistance

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CILASTATIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NETILMICIN; PIPERACILLIN; TICARCILLIN;

ACINETOBACTER; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; FEMALE; HEAD INJURY; HOSPITAL INFECTION; HUMAN; MALE; MENINGITIS; MULTIPLE ORGAN FAILURE; TREATMENT OUTCOME;

ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; CRANIOTOMY; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SKULL FRACTURES;

EID: 0032981921     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Graevenitz von A: Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative Gram-negative bacteria. In: Murray PR, Baron EJ, Pfaller MA, et al, eds. Manual of Clinical Microbiology. Washington DC: ASM Press, 1995:520-32.
2. Allen KD, Green HT: Hospital outbreak of multi-resistant Acinetobacter anitratus: an airborne mode of spread? J Hosp Infect 1987;9:110-9.
3. Bergogne-Berezin E, Joly-Guillou ML: Hospital infection with Acinetobacter spp: an increasing problem. J Hosp Infect 1991;18 (suppl A):250-5.
4. Seifert H, Strate A, Pulverer G: Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology, and predictors of mortality. Medicine 1995;74:340-9.
5. Seifert H, Richter W, Pulverer G: Clinical and bacteriological features of relapsing shunt-associated meningitis due to Acinetobacter baumannii. Eur J Clin Microbiol Dis 1995;14: 130-4.
6. Nguyen MH, Harris SP, Muder RR, et al: Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients. Neurosurgery 1994;35:851-5.
7. Baltas I, Tsoulfa S, Sakellariou P, et al: Posttraumatic meningitis: bacteriology, hydrocephalus, and outcome. Neurosurgery 1994; 35:422-7.
8. Morgan MEI, Hart CA: Acinetobacter meningitis: acquired infection in a neonatal intensive care unit. Arch Dis Child 1982;57:557-9.
9. Barnishan J, Ayers LW: Rapid identification of nonfermentative Gram-negative rods by the Corning N/F system. J Clin Microbiol 1979;9:239-43.
10. Bauer AW, Kirby WMM, Sherris JC, et al: Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
11. Chen YC, Chang SC, Hsieh WC, et al: Acinetobacter calcoaceticus bacteremia: analysis of 48 cases. J Formos Med Assoc 1991;90: 958-63.
12. Chu CL, Chen MC, Chang CH, et al: Investigation of nosocomial Acinetobacter baumannii infections at a medical center. Nosocom Infect Control J 1996;6:63-9.
13. Seifert H, Baginski R, Schulze A, et al: Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother 1993;37:750-3.
14. Ling JM, Ng TK, Cheng AF, et al: Susceptibilities to 23 antimicrobial agents and β-lactamase production of blood culture isolates of Acinetobacter sp in Hong Kong. Scand J Infect Dis 1996; (suppl 101):21-5.
15. Rodriguez K, Dickinson GM, Greenman RL: Successful treatment of Gram-negative bacillary meningitis with imipenem/ cilastatin. South Med J 1985;78:731-2.
16. Blechschmidt B, Borneleit P, Kleber HP: Purification and characterization of an extracellular β-lactamase produced by Acinetobacter calcoaceticus. J Gene Microbiol 1992;138: 1197-1202.
17. Rouveix E, Bure AM, Regnier B, et al: Experience with imipenem/ cilastatin in the intensive care unit. J Antimicrob Chemother 1986;18(suppl E):153-60.
18. Jacobs RF: Imipenem-cilastatin: the first thienamycin antibiotic. Pediatr Infect Dis 1986;5:444-8.
19. Chow AW, Finlay KR, Stiver G, et al: Intrathecal penetration of N-formimidoyl-thienamycin in normal rabbits: potentiation by coadministration of renal dipeptidase enzyme inhibitor. Antimicrob Agents Chemother 1983;23:634-6.
20. Wong VK, Wright HT Jr, Ross LA, et al: Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis 1991;10:122-5.